Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Defensive Interval Ratio
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Defensive Interval Ratio of 3228 days as of September 2025. Defensive assets of $98.34 Million (cash $-, short-term investments $97.46 Million, receivables $879.00K) cover 3228 days of daily cash needs of $30.46K/day. See ARTV current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Artiva Biotherapeutics, Inc. Common Stock Defensive Interval Ratio (2020–2024)
This chart shows how Artiva Biotherapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 3228 days, meaning defensive assets of $98.34 Million can fund 3228 days of operations without new revenue. See Artiva Biotherapeutics, Inc. Common Stoc balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Artiva Biotherapeutics, Inc. Common Stock (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Artiva Biotherapeutics, Inc. Common Stock from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Artiva Biotherapeutics, Inc. Common Stoc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 4329 days | $145.34 Million | $33.57K/day | $- | $145.19 Million | ▲ +3576 days |
| 2023 | 753 days | $25.23 Million | $33.50K/day | $- | $23.47 Million | ▲ +746 days |
| 2022 | 7 days | $525.00K | $70.21K/day | $- | $0.00 | ▼ -1 days |
| 2021 | 9 days | $468.00K | $52.89K/day | $- | $- | ▲ +9 days |
| 2020 | 0 days | $0.00 | $15.79K/day | $- | $- | — |